COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach.
Prog Pediatr Cardiol
; : 101232, 2020 May 23.
Article
in English
| MEDLINE | ID: covidwho-343673
ASO, antistreptolysin O; BNP, brain-natriuretic peptide; CBC, complete blood count; CDC, Center for Disease Control; COVID-19; COVID-19, severe viral respiratory infection caused by SARS-CoV-2; CRP, C-reactive protein; CSS, cytokine storm syndrome; ECMO, extracorporeal membrane oxygenation; Fever; GI, gastrointestinal; HLH, hemophagocytic lymphohistiocytosis; ICU, intensive care unit; IVIG, intravenous immunoglobulin; Inflammation; KD, Kawasaki disease; LDH, lactate dehydrogenase; LFTs, liver function tests; MAS, macrophage activation syndrome; MIS-C; MIS-C, Multisystem Inflammatory Syndrome in Children; PCAID, Pediatric COVID-19 Associated Inflammatory Disorder; PMIS, Pediatric Multisystem Inflammatory Syndrome; PT, prothrombin Time; PTT, partial Thromboplastin Time; Pediatric; SARS-CoV-2; TNF, tumor necrosis factor; VA, veno-arterial; VTE, venous thromboembolic events
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Prog Pediatr Cardiol
Year:
2020
Document Type:
Article
Affiliation country:
J.ppedcard.2020.101232
Similar
MEDLINE
...
LILACS
LIS